VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $220,000 | -71.9% | 13,798 | +214.2% | 0.57% | +117.6% |
| Q3 2015 | $784,000 | +165.8% | 4,392 | +231.2% | 0.26% | +133.9% |
| Q2 2015 | $295,000 | -52.2% | 1,326 | -57.3% | 0.11% | -65.9% |
| Q1 2015 | $617,000 | +124.4% | 3,106 | +47.9% | 0.33% | +412.5% |
| Q3 2014 | $275,000 | -60.3% | 2,100 | -60.0% | 0.06% | -58.7% |
| Q1 2014 | $692,000 | +94.9% | 5,254 | +54.5% | 0.16% | -27.9% |
| Q3 2013 | $355,000 | – | 3,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |